Polyarteritis nodosa and hypertrophic obstructive cardiomyopathy. A true association?

Dimitris P Papadopoulos; Ioannis Moyssakis; Vassilios E Votteas

doi:10.1007/s10067-003-0798-y

Polyarteritis nodosa and hypertrophic obstructive cardiomyopathy. A true association?

Clin Rheumatol. 2004 Feb;23(1):57-8. doi: 10.1007/s10067-003-0798-y. Epub 2003 Nov 7.

Authors

Dimitris P Papadopoulos¹, Ioannis Moyssakis, Vassilios E Votteas

Affiliation

¹ Department of Cardiology, Laiko Hospital of Athens, Athens, Greece. [email protected]

PMID: 14749986
DOI: 10.1007/s10067-003-0798-y

Abstract

A 60-year-old man with polyarteritis nodosa under treatment presented with syncope. Echocardiography demonstrated hypertrophic obstructive cardiomyopathy; coronary arteriography revealed normal findings, and Holter monitor showed episodes of non-sustained ventricular tachycardia. This is the first report of hypertrophic obstructive cardiomyopathy developing in a patient with polyarteritis nodosa. Further studies should examine whether a true association exists.

Publication types

Case Reports

MeSH terms

Amiodarone / therapeutic use
Anti-Arrhythmia Agents / therapeutic use
Cardiomyopathy, Hypertrophic / complications*
Cardiomyopathy, Hypertrophic / drug therapy
Cardiomyopathy, Hypertrophic / pathology
Cyclophosphamide / therapeutic use
Drug Therapy, Combination
Echocardiography
Humans
Immunosuppressive Agents / therapeutic use
Male
Methylprednisolone / therapeutic use
Middle Aged
Polyarteritis Nodosa / complications*
Polyarteritis Nodosa / drug therapy
Polyarteritis Nodosa / pathology
Treatment Outcome
Verapamil / therapeutic use

Substances

Anti-Arrhythmia Agents
Immunosuppressive Agents
Cyclophosphamide
Verapamil
Amiodarone
Methylprednisolone